Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $2.25 billion. The enterprise value is $2.29 billion.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 49.01 million shares outstanding. The number of shares has increased by 16.23% in one year.
| Current Share Class | 49.01M |
| Shares Outstanding | 49.01M |
| Shares Change (YoY) | +16.23% |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 1.74% |
| Owned by Institutions (%) | 92.42% |
| Float | 38.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.49 |
| Forward PS | 5.12 |
| PB Ratio | 9.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 241.55 |
| P/OCF Ratio | 218.32 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 245.56 |
Financial Position
The company has a current ratio of 3.10, with a Debt / Equity ratio of 1.41.
| Current Ratio | 3.10 |
| Quick Ratio | 2.83 |
| Debt / Equity | 1.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | 34.05 |
| Interest Coverage | -6.12 |
Financial Efficiency
Return on equity (ROE) is -37.08% and return on invested capital (ROIC) is -9.95%.
| Return on Equity (ROE) | -37.08% |
| Return on Assets (ROA) | -8.31% |
| Return on Invested Capital (ROIC) | -9.95% |
| Return on Capital Employed (ROCE) | -16.10% |
| Revenue Per Employee | $1.05M |
| Profits Per Employee | -$273,112 |
| Employee Count | 322 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 3.65 |
Taxes
In the past 12 months, MIRM has paid $1.03 million in taxes.
| Income Tax | 1.03M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +83.08% in the last 52 weeks. The beta is 1.04, so MIRM's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +83.08% |
| 50-Day Moving Average | 47.92 |
| 200-Day Moving Average | 42.01 |
| Relative Strength Index (RSI) | 47.11 |
| Average Volume (20 Days) | 495,611 |
Short Selling Information
The latest short interest is 6.28 million, so 12.82% of the outstanding shares have been sold short.
| Short Interest | 6.28M |
| Short Previous Month | 6.63M |
| Short % of Shares Out | 12.82% |
| Short % of Float | 16.17% |
| Short Ratio (days to cover) | 10.54 |
Income Statement
In the last 12 months, MIRM had revenue of $336.89 million and -$87.94 million in losses. Loss per share was -$1.85.
| Revenue | 336.89M |
| Gross Profit | 255.25M |
| Operating Income | -87.61M |
| Pretax Income | -107.43M |
| Net Income | -87.94M |
| EBITDA | -63.98M |
| EBIT | -87.61M |
| Loss Per Share | -$1.85 |
Full Income StatementBalance Sheet
The company has $280.32 million in cash and $317.76 million in debt, giving a net cash position of -$37.45 million or -$0.76 per share.
| Cash & Cash Equivalents | 280.32M |
| Total Debt | 317.76M |
| Net Cash | -37.45M |
| Net Cash Per Share | -$0.76 |
| Equity (Book Value) | 225.64M |
| Book Value Per Share | 4.67 |
| Working Capital | 266.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $10.33 million and capital expenditures -$993,000, giving a free cash flow of $9.33 million.
| Operating Cash Flow | 10.33M |
| Capital Expenditures | -993,000 |
| Free Cash Flow | 9.33M |
| FCF Per Share | $0.19 |
Full Cash Flow StatementMargins
Gross margin is 75.77%, with operating and profit margins of -26.00% and -26.10%.
| Gross Margin | 75.77% |
| Operating Margin | -26.00% |
| Pretax Margin | -25.80% |
| Profit Margin | -26.10% |
| EBITDA Margin | -18.99% |
| EBIT Margin | -26.00% |
| FCF Margin | 2.77% |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.23% |
| Shareholder Yield | n/a |
| Earnings Yield | -3.90% |
| FCF Yield | 0.41% |
Dividend DetailsAnalyst Forecast
The average price target for MIRM is $58.55, which is 27.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $58.55 |
| Price Target Difference | 27.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 26.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 1.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 4 |